Logo

Illumina Ventures: Arnaud Autret, William Byrne, Ronan Byrne, and Ivan Coulter

Aug 05, 2022

Illumina Ventures has added Arnaud Autret as principal and head of European operations, William Byrne as an associate, and Ronan Byrne and Ivan Coulter as venture advisors. 

Autret comes to the firm from M Ventures, the venture capital arm of Merck KGaA. He holds a doctorate in immunology from the Pasteur Institute. 

William Byrne holds a doctorate in tumor immunology from University College Cork and an MBA from INSEAD. 

Ronan Byrne is CEO and cofounder of Pharma Latch. He holds an MBA from University College Dublin. 

Coulter is founder and managing director of Eden BioPharma. He holds a doctorate in cancer research from University College Dublin and an MBA from Cornell University.

Breaking News
The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.